Heparin sodium 25,000 units in dextrose 5% side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Heparin sodium 25,000 units in dextrose 5%. Common side effects include gastrointestinal haemorrhage among females and activated partial thromboplastin time prolonged among males.

The phase IV clinical study is created by eHealthMe based on 45 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 19, 2022

45 people who take Heparin Sodium 25,000 Units In Dextrose 5% and have side effects are studied.


What is Heparin Sodium 25,000 Units In Dextrose 5%?

Heparin sodium 25,000 units in dextrose 5% has active ingredients of heparin sodium. eHealthMe is studying from 45 Heparin sodium 25,000 units in dextrose 5% users for its effectiveness, alternative drugs and more.

Number of Heparin sodium 25,000 units in dextrose 5% reports submitted per year:

Heparin sodium 25,000 units in dextrose 5% side effects.

Heparin Sodium 25,000 Units In Dextrose 5% side effects by time on the drug*:

< 1 month:

  1. Activated partial thromboplastin time prolonged
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Haematemesis (vomiting of blood)
  4. Haematoma (collection of blood outside the blood vessels)
  5. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Hypotension (abnormally low blood pressure)
  8. Rash pruritic (redness with itching)
  9. Rectal haemorrhage (bleeding from anus)
  10. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Renal failure (kidney dysfunction)
  2. Acute circulatory failure (shock)
  3. Anxiety
  4. Brain death
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Drug effect decreased
  7. Extradural haematoma (traumatic brain injury-collection of blood in the 'potential' space between the skull and the outer protective)
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Hypersensitivity
  10. Platelet count decreased

Heparin Sodium 25,000 Units In Dextrose 5% side effects by gender *:

female:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Haemorrhage (bleeding)
  3. Acute myocardial infarction (acute heart attack)
  4. Brain death
  5. Cardiac failure congestive
  6. Cerebral haemorrhage (bleeding within the brain)
  7. Extradural haematoma (traumatic brain injury-collection of blood in the 'potential' space between the skull and the outer protective)
  8. Haematoma (collection of blood outside the blood vessels)
  9. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  10. Hypersensitivity

male:

  1. Activated partial thromboplastin time prolonged
  2. Renal failure (kidney dysfunction)
  3. Haematemesis (vomiting of blood)
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Platelet count decreased
  6. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  7. Unresponsive to stimuli
  8. Acute circulatory failure (shock)
  9. Anxiety
  10. Arterial thrombosis (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system)

Heparin Sodium 25,000 Units In Dextrose 5% side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypotension (abnormally low blood pressure)

40-49:

  1. Activated partial thromboplastin time prolonged
  2. Brain death
  3. Hyperkalaemia (damage to or disease of the kidney)

50-59:

  1. Acute myocardial infarction (acute heart attack)
  2. Catheter site discharge
  3. Extradural haematoma (traumatic brain injury-collection of blood in the 'potential' space between the skull and the outer protective)
  4. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

60+:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Drug effect decreased
  4. Drug ineffective
  5. Haematemesis (vomiting of blood)
  6. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  7. Hypersensitivity
  8. Platelet count decreased
  9. Rash pruritic (redness with itching)
  10. Rectal haemorrhage (bleeding from anus)

* Approximation only. Some reports may have incomplete information.

Do you take Heparin sodium 25,000 units in dextrose 5%?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on heparin sodium (the active ingredients of Heparin sodium 25,000 units in dextrose 5%) and Heparin sodium 25,000 units in dextrose 5% (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Heparin sodium 25,000 units in dextrose 5%:

All Heparin sodium 25,000 units in dextrose 5% side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: